SUMMA
The etiology of congenital heart lesions is varied and multifactorial hypothesis has gained wide acceptance. Regardless of the etiologic agent, the offending factor must act through a common pathway by either changing the growth rate, the resorptive process or the molding mechanical effect of the circulating blood. In search of a model for producing congenital heart disease in a reproducible fashion we used 8-azaguanine (a purine analogue) to study the effects of growth inhibition on developing chick embryo hearts. One half ml of 8-azaguanine (25mg% solution) was injected into the yolk sac of fertile white Leghorn eggs at 23rd stage. Eggs injected with 1/2ml of normal saline served as control. Eight-azaguanine-treated eggs delivered less normal embryos (29/188) than the saline-injected eggs (119/158, p<0.001) and more dead embryos (106/188 vs 0/158 respectively, p<0.001).
Serial sections of the hearts extracted at 35th stage in the 8-azaguanine-treated (64 specimens) and control group (96 specimens) revealed no congenital heart defect in the latter group, whereas the development of the hearts were halted either in the tubular stage (12/64, p<0.01) or in the primitive stages of development (28/64, p<0.001).
The thickness of the ventricular myocardium was also greatly reduced.
It is concluded that: 1) Certain types of congenital heart defects such as endocardial cushion defect, and common ventricle could be reproducibly produced by growth inhibiting agent 8-azaguanine in the chick embryo. 2) Experimental models for production of congenital heart defects through acceleration of the growth or changing the rate of tissue resorption must be sought.
Additional Indexing Words: DNA synthesis RNA synthesis Purine analogues Etiology of congenital heart defects Endocardial cushion defect Common ventricle HE development of the heart from its primordial bitubular form into its complete final structure necessitates an orderly progression of timed growth of various sections occurring simultaneously with resorption of tissues.1),2) In addition, the molding effect of circulating blood bears significant effect on cardiac development.3) In about 8% of patients with congenital heart defect genetic factors with little or no environmental influence form the etiologic basis; in 2% environmental factors play a role without an apparent genetic background, and in the remaining 90% a genetic-environmental interaction (multifactorial inheritance) is felt responsible.4)-6) Regardless of the type of congenital heart defect and its etiology, an environmental factor must eventually alter (increase or decrease) either the rate of growth, or resorption of cardiac primordial structures. Experiments on the molding effect of circulating blood have already demonstrated the significance of such interventions.3),7)-9) We have studied the effects of 8-azaguanine and its resultant growth retardation on the development of chick embryo heart. This report is intended to demonstrate the teratogenic effects of this agent. The number of amorphous embryos was significantly different among the 3 groups. There were 106 dead embryos in Group I vs no dead embryos in Groups II and III (p<0.001).
The results of microscopic examination of the embryonic hearts were summarized in Table II . Sixty-four of the hearts treated with 8-azaguanine , 96 treated with normal saline, and 51 embryos without any intervention were examined by serial section. There were no cardiac anomalies in Groups II or III, however significant developmental aberrations were detected in Jap. Heart J. January, 1980 Fig. 1 Vol. 21 No.1
Group I embryos. The hearts in Group I embryos could be divided into 3 groups: a. Normal hearts: 24 out of 64 specimens (37%) were normal, however the thickness of the ventricular myocardium was grossly reduced compared to the normal embryos of comparable age.
b. Tubular hearts: (12 out of 64 specimens, 18%). In these specimens the growth of the cardiac anlage was inhibited at its tubular stage with only minimal convolution (Fig. 1A) . Thus these hearts extracted from 8 1/2-day-old embryos were similar to a normal 3 1/2-day-old embryo ( Fig.  2-B) .
c. Primitive hearts: In 28 out of 64 specimens (43%), the cardiac development was retarded. The developmental retardation was accompanied by severe inhibition of tissue growth, similar to the normal hearts (see "a" above), the thickness of the ventricular myocardium being significantly reduced for age ( Fig. 1-B, 1-C, and 1-D) . The hearts in this group were generally similar to 4 1/2 to 5-day-old embryos ( Fig. 2-C, 2-D) . Anatomically they could be considered as having complete form of endocardial cushion defect and common ventricle ( Fig. 1-B, 1-C, and 1-D) . No instances of transposition of the great arteries or tetralogy of Fallot were noted. These results were statistically significant (Table II) .
DISCUSSI
Despite the influence of genetic and environmental factors in some instances, in the majority of cases, the etiology of congenital heart disease remains elusive. The multifactorial hypothesis concerning etiology of congenital heart disease has gained wide acceptance.4)-6) Regardless of the etiologic factor, i.e. environmental and/or genetic, the offending factor must act through changing 1 of the 3 basic processes involved in cardiac development, i.e. the Fig. 2 . This series of figures show normal chick embryo hearts, at various stages of development (Fig. 2-A, 2-day-old; Fig. 2 rate of growth, the rate of resorptive phenomenon13)-15) and the mechanical molding effect of the circulating blood.3),8),9),16) The purpose of the present investigation was: 1) to study specific effects of growth inhibition in the embryonic chicken heart, using a purine analogue, and 2) to observe whether or not a uniform effect could be produced by this teratogenic agent in an experimental model, because most teratogenic agents produce nonspecific cardiac Jap. Heart J. January, 1980 anomalies.1),2),4)-6) Therefore, searching for an agent which could give rise to reproducible anomalies is of interest.
Our experiments showed that eggs injected with normal saline were similar to those which underwent no intervention. Thus the number of dead embryos and cardiac structures were not different in these 2 control groups. In contrast injecting chick embryos with 8-azaguanine during the critical stage of cardiac development, i.e. 23rd stage, caused significant growth inhibition. Thus the hearts of 35th stage (8 1/2-day-old) embryos were either halted in the tubular stage ( Fig. 1-A) or developed only to the stage of a 3 1/2-4-day-old embryo ( Fig. 1-B, 1-C, and 1-D) , whereas normally the heart was fully developed at this stage in Groups II and III (Fig. 2-E and 2-F) . Thus should these embryos had developed into adults chicks, their hearts could have been classified as having complete endocardial cushion defect or common ventricle. Moreover the inhibition of growth at this critical stage caused reproducible defects.
Two basic processes of cardiac growth in the chick embryo are cell hyperplasia and cell hypertrophy.17) The former is the principal process by which the heart grows up to 16th day. Doyle and Zak18) reported that there was continuous decrease in DNA accumulation (an index of cell hyperplasia) in the ventricles of chick embryos between 8th to 18th days of incubation. DNA synthesis stops at 20th day and further growth is accomplished through cell hypertrophy. Eight-azaguanine (a purine analogue) may affect embryonic cardiac growth through one or more of the following mechanisms:
1. 8-azaguanine inhibits the formation of 18-S ribosomal RNA (rRNA) which inhibits protein synthesis. 19) 2. Inhibition of protein synthesis may affect the histone and nonhistone proteins which regulate different stages of development. 20) 3. There is considerable body of evidence, that in eukaryotes RNA synthesis is necessary for priming DNA chain initiation.21),22) Thus 8-azaguanine affects growth by both inhibition of cell replication (hyperplasia) and cell growth.
We believe that irrespective of the etiologic agent, an offending factor causes cardiac malformation through either changing the growth rate, the rate of tissue resorption or the molding effect of the circulating blood. Anomalies such as endocardial cushion defect, common ventricle and truncus arteriosus communis could be explained by inhibition of growth or improper timing of growing elements. Eight-azaguanine caused endocardial cushion defect and common ventricle because of growth inhibition. Anomalies such as pulmonic stenosis, aortic stenosis, tricuspid atresia, hypoplastic left heart, mitral atresia, pulmonary atresia, could be due to lack of normal molding effect of circulating blood,3),7)-9) and finally anomlies such as Ebstein's anomaly of the tricuspid valve,13) certain ventricular septal defects,14) and conduction problems23) and pulmonary valvular dysplasia could be due to abnormal resorptive process involved in molding and final shaping of the heart.
